2011 annual financial data
Regeneron Pharmaceuticals 2011 Operating margin
Direct answer
Operating margin was -46.02%.
Operating income was -205,159,000 USD and net income was -221,760,000 USD.
Operating cash flow was -141,682,000 USD.
Get free Regeneron Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 445,824,000 USD
- Operating income
- -205,159,000 USD
- Net income
- -221,760,000 USD
- Operating cash flow
- -141,682,000 USD